Rapid TB Diagnostics Development Network Episode 2
Official title: Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
Funded at University of California, San Francisco · NIH-11607822 · Data updated 2026-11-12
A national network is testing and linking new TB diagnostic technologies with clinical sites to speed up accurate, affordable testing for people in high-burden regions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 11, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $525,378 |
| NIH project number | 3R01AI190419-02S7 |
| Project ID | NIH-11607822 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals in high TB burden regions who would benefit from earlier, more accurate TB diagnosis and drug resistance detection.
✕Less likely to help
Patients in settings where the selected tests are not yet available or not applicable to their care pathway.
What this research studies
This grant supports a collaborative effort to identify promising TB tests and connect developers with experienced clinical sites for real-world evaluation. Researchers will curate a portfolio of diagnostics across development stages and use cases, aligning them with WHO target profiles. The goal is to shorten the time from test development to reliable, accessible diagnostics that can be used at lower levels of healthcare and improve patient outcomes.
Why it matters
Potential benefit: If successful, patients in high TB burden settings could receive faster, more accurate diagnosis and treatment guidance, reducing transmission and mortality.
How similar studies have gone: Past TB diagnostic development efforts have advanced several promising tests, but broad, real-world validation and deployment remain challenging and ongoing.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Nahid, Payam — University of California, San Francisco
- Study coordinator: Nahid, Payam
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.